Yemen | News | WHO and IsDB in Yemen: ensuring treatment for children with genetic blood disorders

WHO in Yemen

WHO and IsDB in Yemen: ensuring treatment for children with genetic blood disorders

Print PDF

WHO and IsDB in Yemen: ensuring treatment for children with genetic blood disorders

23 February 2022- Thousands of Yemeni children and adolescents suffer from thalassemia, a genetic blood disorder that causes anemia, fatigue, stunting, and even death. The disorder is manageable with blood transfusions and iron-chelating drugs, and patients who are treated can live normal lives. But the country's ongoing conflict has severely disrupted the supply of essential medicines for blood disorders, putting the health and lives of patients at risk.

Read the full story

Arabic version of the story